Effect of Conclevan on Endurance Capacity in Mice
スポンサーリンク
概要
- 論文の詳細を見る
The purpose of this study was to clarify the anti-fatigue effect of Conclevan, which is mainly composed of liver hydrolysate, via a forced swimming test using mice. Conclevan was administered to mice for 6 weeks, and a forced swimming test was conducted to measure swimming time. After six weeks, the blood ammonia and glutamine concentrations were measured. In the Conclevan administration group, swimming time increased significantly compared to the swimming control group. In the swimming control group, an increase in blood ammonia and a decrease in blood glutamine were observed, relative to the non-swimming control group. In the Conclevan administration group, the increased blood ammonia and decreased blood glutamine induced by swimming were significantly reduced, compared to the swimming control group. The mRNA expression levels of the hepatic enzymes of the urea cycle (carbamoyl-phosphate synthetase, argininosuccinate synthetase, and arginase) and glutamine synthesis (glutamate dehydrogenase and glutamine synthetase) were significantly increased in the Conclevan administration group, compared to the swimming control group. The results of this study demonstrated the anti-fatigue effects of Conclevan. This product may inhibit an increase in the fatigue-inducing ammonia concentration in the blood by increasing the expression of hepatic enzymes, which convert ammonia to urea, leading to increased swimming time. In addition, Conclevan may prolong swimming time by increasing the hepatic synthesis of glutamine, which is an important amino acid for supplying energy in muscles.
- 公益社団法人 日本薬学会の論文
著者
-
Ikarashi Nobutomo
Department of Clinical Pharmacokinetics, School of Pharmacy and Pharmaceutical Sciences, Hoshi Unive
-
Toda Takahiro
Department of Clinical Pharmacokinetics, School of Pharmacy and Pharmaceutical Sciences, Hoshi Unive
-
Toda Takahiro
Dep. Of Clinical Pharmacokinetics Hoshi Univ.
-
Ochiai Wataru
Department Of Anatomy And Cell Biology Nagoya University Graduate School Of Medicine
-
Sugiyama Kiyoshi
Department Of Clinical Pharmacokinetics Hoshi University
-
Ishii Makoto
Department Of Environmental Chemistry And Engineering Tokyo Institute Of Technology
-
Fukazawa Yoko
Department of Clinical Pharmacokinetics, Hoshi University
-
Usukura Masatoshi
Nissui Pharmaceutical Co., Ltd.
-
Ikarashi Nobutomo
Department of Clinical Pharmacokinetics, Hoshi University
-
TODA Takahiro
Department of Clinical Pharmacokinetics, Hoshi University
-
Ishii Makoto
Department of Clinical Pharmacokinetics, Hoshi University
関連論文
- Effects of Kampo medicines on Cyp3a and P-glycoprotein activity in vivo
- 21D-12 複方オキシコドン注射液含有成分ヒドロコタルニンによる薬物間相互作用の検討(薬物相互作用,来るべき時代への道を拓く)
- P2-226 チトクロムP450およびP-糖タンパク質に及ぼす大建中湯の影響(一般演題 ポスター発表,薬物動態(基礎),医療薬学の創る未来 科学と臨床の融合)
- 漢方専門外来受診患者における漢方薬服用に関する実態調査 : 漢方薬に対する患者の認識とコンプライアンス
- 21-P3-544 電子カルテを用いた大学院生の病院実習(薬学教育(実務実習),来るべき時代への道を拓く)
- 21-P2-374 フルオレセイン含有ベノキシール点眼液の製剤改良(院内製剤・薬局製剤,来るべき時代への道を拓く)
- 21-P2-301 緑茶微粉末加工食品フォースSODのシスプラチン腎毒性軽減メカニズムの検討(がん薬物療法(副作用対策),来るべき時代への道を拓く)
- 20-P3-471 肝臓における薬物トランスポーターの発現に及ぼす腸内細菌の影響(薬物動態(基礎),来るべき時代への道を拓く)
- 20-P3-470 肥満型糖尿病モデルTSODマウスの肝臓における薬物トランスポーターの発現変動(薬物動態(基礎),来るべき時代への道を拓く)
- 21I-12 出生および加齢によるCyp3a発現量の変化(薬物動態(基礎・臨床・遺伝子多型),来るべき時代への道を拓く)
- 21I-05 白虎加人参湯によるアクアポリンの発現変化(薬物療法,来るべき時代への道を拓く)
- 21I-04 塩類下剤硫酸マグネシウムによる腸管アクアポリンの発現変化(薬物療法,来るべき時代への道を拓く)
- Fatal Alveolar Hemorrhage in a Patient with Mixed Connective Tissue Disease Presenting Polymyositis Features
- Effects of Magnesium Sulphate Administration on Aquaporin 3 in Rat Gastrointestinal Tract
- Fate redirection of hippocampal astrocytes toward neuronal lineage by aggregate culture
- Fate alteration of neuroepithelial cells from neurogenesis to astrocytogenesis by bone morphogenetic proteins
- O5-01 糖尿病に伴う多尿時におけるジゴキシンの体内動態の変動(一般演題 口頭発表,薬物動態・TDM・投与設計,臨床から学び臨床へと還元する医療薬学)
- O12-009 後発品使用促進の現状と問題点 : 後発医薬品は薬剤師に受け入れられているのか?(一般演題 口頭発表,糖尿病/使用状況調査・意識調査,医療薬学の創る未来 科学と臨床の融合)
- SIGNIFICANCE OF WALL SHEAR RATE FOR ICAM-1-DEPENDENT LEUKOCYTE RECRUITMENT IN THE MICROCIRCULATION OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS
- Effects of Kampo Medicines on P-Glycoprotein
- Effects of Kampo Medicines on CYP and P-gp Activity in Vitro(Pharmacology)
- Preparation of a Clonidine Ointment and its Application to Sympathetically Maintained Pain (SMP)
- Juzentaihoto reduces post-partial hepatectomy hyperammonemia by stabilizing intestinal microbiota
- Increases in the Expression Levels of Aquaporin-2 and Aquaporin-3 in the Renal Collecting Tubules Alleviate Dehydration Associated with Polyuria in Diabetes Mellitus
- Transformation of pin-like ventricular zone cells into cortical neurons
- THE INHIBITORY EFFECT OF KAMPOU EXTRACTS ON IN VITRO CALCIUM OXALATE CRYSTALLIZATION AND IN VIVO STONE FORMATION IN AN ANIMAL MODEL
- シプロフロキサシン投与による腸内細菌の減少に伴うCyp3aの減少
- Cytochrome P450 およびP-糖蛋白質に及ぼす hydrocotarnine の影響
- Effectiveness of the Fold Plication Method in Lung Volume Reduction Surgery
- Contribution of Airway Resistance to Airway Pressure during Mechanical Ventilation : an Experimental Study
- The Threshold of the Intermittent Hypoxic Exposure Period to Elicit Polycythemia in Rats
- Rate Enhancing Effect of Carbon Dioxide in the Reaction of Acetonitrile with Methanol to Acrylonitrile over Magnesium Oxide Catalyst
- Disposition of a New Tamibarotene Prodrug in Mice
- 胃切除によってCytochrome P450の発現量および活性が増加する(一般演題(口頭)24,薬物治療と遺伝子多型・薬物動態(基礎)(1),Enjoy Pharmacists' Lifestyles)
- 妊娠中に高脂肪食を摂取すると仔の肝臓のCytochrome P450の活性が低下する(一般演題(口頭)9,妊婦・授乳婦・腎疾患,Enjoy Pharmacists' Lifestyles)
- P-0658 ワルファリンの抗凝血作用に及ぼすメントールの影響(一般演題 ポスター発表,薬物相互作用,Enjoy Pharmacists' Lifestyles)
- Electron Microscopic Observation of Oxides Formed on Thin Film of Copper at Elevated Temperature
- Inhibition of Aquaporin-3 Water Channel in the Colon Induces Diarrhea
- Effect of Conclevan on Endurance Capacity in Mice
- Consumption of a High-Fat Diet during Pregnancy Changes the Expression of Cytochrome P450 in the Livers of Infant Male Mice
- Different Diets Cause Alterations in the Enteric Environment and Trigger Changes in the Expression of Hepatic Cytochrome P450 3A, a Drug-Metabolizing Enzyme
- P2-364 妊娠期の高脂肪食摂取が仔の各Cytochrome P450分子種の発現に与える影響(薬物動態・TDM・投与設計,ポスター,一般演題,岐路に立つ医療〜千年紀の目覚め〜よみがえれ!ニッポン!薬の改革は我らが手で!)
- P2-231 浸透圧性下剤および大腸刺激性下剤を併用しても、瀉下作用は増強しない(薬物相互作用,ポスター,一般演題,岐路に立つ医療〜千年紀の目覚め〜よみがえれ!ニッポン!薬の改革は我らが手で!)
- P1-309 神経障害性疼痛時にはモルヒネの脳内到達量が減少する(がん薬物療法(緩和ケア),ポスター,一般演題,岐路に立つ医療〜千年紀の目覚め〜よみがえれ!ニッポン!薬の改革は我らが手で!)
- Gastrectomy increases the expression of hepatic cytochrome P450 3A by increasing lithocholic acid-producing enteric bacteria in mice